Full Text Journal Articles in
Journal Lancet Diabetes Endocrinol

Advertisement

Find full text journal articles






Post-exercise recovery for the endurance athlete with type 1 diabetes: a consensus statement.

Sam N Scott, Federico Y Fontana, Matt Cocks, James P Morton, Asker Jeukendrup, Radu Dragulin, Jørgen F P Wojtaszewski, Jørgen Jensen, Rafael Castol, Michael C Riddell, Christoph Stettler, ,

There has been substantial progress in the knowledge of exercise and type 1 diabetes, with the development of guidelines for optimal glucose management. In addition, an increasing number of people living with type 1 diabetes are pushing their physical limits to compete at the highest level of sport. However, the ... Read more >>

Lancet Diabetes Endocrinol (The lancet. Diabetes & endocrinology)
[2021, 9(5):304-317]

Cited: 0 times

View full text PDF listing >>



Fluid volume regulation in patients with heart failure.

Panagiota Anyfanti, Erasmia Sampani, Apostolos Tsapas,

Lancet Diabetes Endocrinol (The lancet. Diabetes & endocrinology)
[2021, 9(5):257-258]

Cited: 0 times

View full text PDF listing >>



Advertisement

Fluid volume regulation in patients with heart failure.

Atsushi Tanaka, Koichi Node,

Lancet Diabetes Endocrinol (The lancet. Diabetes & endocrinology)
[2021, 9(5):256-257]

Cited: 0 times

View full text PDF listing >>



Semaglutide for obesity: four STEPs forward, but more to come.

Donna H Ryan,

Lancet Diabetes Endocrinol (The lancet. Diabetes & endocrinology)
[2021, 9(5):252-254]

Cited: 0 times

View full text PDF listing >>



A community-based, multi-level, multi-setting, multi-component intervention to reduce weight gain among low socioeconomic status Latinx children with overweight or obesity: The Stanford GOALS randomised controlled trial.

Thomas N Robinson, Donna Matheson, Darrell M Wilson, Dana L Weintraub, Jorge A Banda, Arianna McClain, Lee M Sanders, William L Haskell, K Farish Haydel, Kristopher I Kapphahn, Charlotte Pratt, Kimberly P Truesdale, June Stevens, Manisha Desai,

<h4>Background</h4>There are few long-term studies of interventions to reduce in low socioeconomic status children with overweight or obesity. The Stanford GOALS trial evaluated a 3-year, community-based, multi-level, multi-setting, multi-component (MMM) systems intervention, to reduce weight gain among low socioeconomic status, Latinx children with overweight or obesity.<h4>Methods</h4>We did a two-arm, parallel ... Read more >>

Lancet Diabetes Endocrinol (The lancet. Diabetes & endocrinology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Mapping overdiagnosis of thyroid cancer in China.

Mengmeng Li, Rongshou Zheng, Luigino Dal Maso, Siwei Zhang, Wenqiang Wei, Salvatore Vaccarella,

Lancet Diabetes Endocrinol (The lancet. Diabetes & endocrinology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Elizabeth Pearce: maintaining the fight against iodine deficiency.

Ray Cavanaugh,

Lancet Diabetes Endocrinol (The lancet. Diabetes & endocrinology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



New insights into the association between body-mass index and severe COVID-19.

Krishnan Bhaskaran,

Lancet Diabetes Endocrinol (The lancet. Diabetes & endocrinology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study.

Min Gao, Carmen Piernas, Nerys M Astbury, Julia Hippisley-Cox, Stephen O'Rahilly, Paul Aveyard, Susan A Jebb,

<h4>Background</h4>Obesity is a major risk factor for adverse outcomes after infection with SARS-CoV-2. We aimed to examine this association, including interactions with demographic and behavioural characteristics, type 2 diabetes, and other health conditions.<h4>Methods</h4>In this prospective, community-based, cohort study, we used de-identified patient-level data from the QResearch database of general practices ... Read more >>

Lancet Diabetes Endocrinol (The lancet. Diabetes & endocrinology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Fluid volume regulation in patients with heart failure - Authors' reply.

Jesper Jensen, Massar Omar, Jacob Eifer Møller, Morten Schou,

Lancet Diabetes Endocrinol (The lancet. Diabetes & endocrinology)
[2021, 9(5):258]

Cited: 0 times

View full text PDF listing >>



The knowns and unknowns of teprotumumab for thyroid eye disease.

Tomasz Bednarczuk, Simon H Pearce,

Lancet Diabetes Endocrinol (The lancet. Diabetes & endocrinology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Tackling childhood obesity in low-socioeconomic status communities: what is the next step?

Romy Gaillard,

Lancet Diabetes Endocrinol (The lancet. Diabetes & endocrinology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Petrifying: ears as hard as stone in adrenal insufficiency.

Swantje Kannenberg, Svenja Meyhöfer, Hendrik Lehnert, Sebastian M Schmid,

Lancet Diabetes Endocrinol (The lancet. Diabetes & endocrinology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Distinguishing the real from the hyperglycaemia: does COVID-19 induce diabetes?

Mark A Atkinson, Alvin C Powers,

Lancet Diabetes Endocrinol (The lancet. Diabetes & endocrinology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials.

George J Kahaly, Raymond S Douglas, Robert J Holt, Saba Sile, Terry J Smith,

<h4>Background</h4>Thyroid eye disease manifests inflammation and treatment-resistant proptosis and diplopia. Teprotumumab, an insulin-like growth factor-1 receptor inhibiting monoclonal antibody, was approved in the USA on Jan 21, 2020, on the basis of two randomised trials. In this analysis we evaluated the short-term and long-term aggregate response to teprotumumab from the ... Read more >>

Lancet Diabetes Endocrinol (The lancet. Diabetes & endocrinology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Towards unified and impactful policies to reduce ultra-processed food consumption and promote healthier eating.

Barry M Popkin, Simon Barquera, Camila Corvalan, Karen J Hofman, Carlos Monteiro, Shu Wen Ng, Elizabeth C Swart, Lindsey Smith Taillie,

The global surges in obesity and nutrition-related non-communicable diseases (NCDs) have created a need for decisive new food policy initiatives. A major concern has been the impact of ultra-processed foods (UPFs) and ultra-processed drinks on weight gain and on the risk of several NCDs. These foods, generally high in calories, ... Read more >>

Lancet Diabetes Endocrinol (The lancet. Diabetes & endocrinology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



The WHO Global Diabetes Compact: a new initiative to support people living with diabetes.

Daniel Hunt, Bianca Hemmingsen, Alena Matzke, Cherian Varghese, Asmus Hammerich, Silvana Luciani, Anselm Hennis, Francesco Branca, Fiona Bull, Nino Berdzuli, Jean-Marie Dangou, Razia Pendse, Angela Pratt, Bente Mikkelsen,

Lancet Diabetes Endocrinol (The lancet. Diabetes & endocrinology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Microvascular disease in diabetes and severe COVID-19 outcomes - Authors' reply.

Helen M Colhoun, Stuart J McGurnaghan, Paul M McKeigue,

Lancet Diabetes Endocrinol (The lancet. Diabetes & endocrinology)
[2021, 9(4):201]

Cited: 0 times

View full text PDF listing >>



Diabetes in pregnancy: time to focus on women with type 2 diabetes.

Jane Elizabeth Hirst, Charlotte Frise, Gaya Thanabalasingham, Katharine Owen,

Lancet Diabetes Endocrinol (The lancet. Diabetes & endocrinology)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.

Ioanna Gouni-Berthold, Veronica J Alexander, Qingqing Yang, Eunju Hurh, Elisabeth Steinhagen-Thiessen, Patrick M Moriarty, Stephen G Hughes, Daniel Gaudet, Robert A Hegele, Louis St L O'Dea, Erik S G Stroes, Sotirios Tsimikas, Joseph L Witztum, ,

<h4>Background</h4>Volanesorsen is an antisense oligonucleotide that targets hepatic apolipoprotein C-III synthesis and reduces plasma triglyceride concentration. The aim of this study was to explore the safety and efficacy of volanesorsen in patients with multifactorial chylomicronaemia syndrome.<h4>Methods</h4>The COMPASS trial was a randomised, placebo-controlled, double-blind, phase 3 study done at 38 international ... Read more >>

Lancet Diabetes Endocrinol (The lancet. Diabetes & endocrinology)
[2021, 9(5):264-275]

Cited: 0 times

View full text PDF listing >>



Addressing health disparities: no time like the present.

The Lancet Diabetes Endocrinology,

Lancet Diabetes Endocrinol (The lancet. Diabetes & endocrinology)
[2021, 9(5):247]

Cited: 0 times

View full text PDF listing >>



Insulin storage without refrigeration.

Munyaradzi Makoni,

Lancet Diabetes Endocrinol (The lancet. Diabetes & endocrinology)
[2021, 9(4):202]

Cited: 0 times

View full text PDF listing >>



Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England.

Kamlesh Khunti, Peter Knighton, Francesco Zaccardi, Chirag Bakhai, Emma Barron, Naomi Holman, Partha Kar, Claire Meace, Naveed Sattar, Stephen Sharp, Nicholas J Wareham, Andy Weaver, Emilia Woch, Bob Young, Jonathan Valabhji,

<h4>Background</h4>In patients with type 2 diabetes, hyperglycaemia is an independent risk factor for COVID-19-related mortality. Associations between pre-infection prescription for glucose-lowering drugs and COVID-19-related mortality in people with type 2 diabetes have been postulated but only investigated in small studies and limited to a few agents. We investigated whether there ... Read more >>

Lancet Diabetes Endocrinol (The lancet. Diabetes & endocrinology)
[2021, 9(5):293-303]

Cited: 1 time

View full text PDF listing >>



A compass for navigating the perils of hypertriglyceridaemia.

Gerald F Watts, Natalie C Ward,

Lancet Diabetes Endocrinol (The lancet. Diabetes & endocrinology)
[2021, 9(5):248-249]

Cited: 0 times

View full text PDF listing >>



Vitamin D to prevent acute respiratory infections.

Paul Lips,

Lancet Diabetes Endocrinol (The lancet. Diabetes & endocrinology)
[2021, 9(5):249-251]

Cited: 0 times

View full text PDF listing >>



Advertisement

Disclaimer
0.9236 s